Search Results - "Boxer, Adam"

Frontotemporal lobar degeneration targets brain regions linked to expression of recently evolved genes.

Authors: Pasquini, Lorenzo Pereira, Felipe L Seddighi, Sahba et al.

Source: Brain: A Journal of Neurology; Sep2024, Vol. 147 Issue 9, p3032-3047, 16p

Clinical dimensions along the non-fluent variant primary progressive aphasia spectrum.

Authors: Illán-Gala, Ignacio Lorca-Puls, Diego L Tee, Boon Lead et al.

Source: Brain: A Journal of Neurology; Apr2024, Vol. 147 Issue 4, p1511-1525, 15p

Neural basis of speech and grammar symptoms in non-fluent variant primary progressive aphasia spectrum.

Authors: Lorca-Puls, Diego L Gajardo-Vidal, Andrea Mandelli, Maria Luisa et al.

Source: Brain: A Journal of Neurology; Feb2024, Vol. 147 Issue 2, p607-626, 20p

Cognitive deficits in progressive supranuclear palsy on the Repeatable Battery for the Assessment of Neuropsychological Status.

Authors: Duff, Kevin McDermott, Dana Luong, Dan et al.

Source: Journal of Clinical & Experimental Neuropsychology. Jul2019, Vol. 41 Issue 5, p469-475. 7p. 3 Charts, 2 Graphs.

Subjects: Progressive supranuclear palsy, Neuropsychological tests, Perception testing, Electric batteries, Functional assessment, Montreal Cognitive Assessment

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Right temporal degeneration and socioemotional semantics: semantic behavioural variant frontotemporal dementia.

Authors: Younes, Kyan Borghesani, Valentina Montembeault, Maxime et al.

Source: Brain: A Journal of Neurology; Nov2022, Vol. 145 Issue 11, p4080-4096, 17p

Low neural exosomal levels of cellular survival factors in Alzheimer's disease.

Authors: Goetzl, Edward J. Boxer, Adam Schwartz, Janice B. et al.

Source: Annals of Clinical & Translational Neurology. Jul2015, Vol. 2 Issue 7, p769-773. 5p.

Lower White Matter Volume and Worse Executive Functioning Reflected in Higher Levels of Plasma GFAP among Older Adults with and Without Cognitive Impairment.

Authors: Asken, Breton M. VandeVrede, Lawren Rojas, Julio C. et al.

Source: Journal of the International Neuropsychological Society; Jul2022, Vol. 28 Issue 6, p588-599, 12p

Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations.

Authors: Boeve, Bradley F Boxer, Adam L Kumfor, Fiona et al.

Source: Lancet Neurology. Mar2022, Vol. 21 Issue 3, p258-272. 15p.

Key Stage 3 science: Wasted years no longer.

Authors: Boxer, Adam¹

Source: Impact (2514-6955). Spring2018, Issue 2, p30-32. 3p.

Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease.

Authors: Spina, Salvatore Joie, Renaud La Petersen, Cathrine et al.

Source: Brain: A Journal of Neurology; Jul2021, Vol. 144 Issue 7, p2186-2198, 13p

18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.

Authors: Soleimani-Meigooni, David N Iaccarino, Leonardo Joie, Renaud La et al.

Source: Brain: A Journal of Neurology; Nov2020, Vol. 143 Issue 11, p3477-3494, 18p

Clinical versus biomarker-based diagnosis of neurocognitive disorders.

Authors: Höglinger, Günter U Boxer, Adam L Lang, Anthony E

Source: Lancet Neurology. Aug2024, Vol. 23 Issue 8, p765-766. 2p.

Disease-Modifying Treatments for Progressive Supranuclear Palsy.

Authors: Stamelou, Maria Boxer, Adam L.

Source: Movement Disorders Clinical Practice. Mar2015, Vol. 2 Issue 1, p3-5. 3p.

Neuropathological correlates of structural and functional imaging biomarkers in 4-repeat tauopathies.

Authors: Spina, Salvatore Brown, Jesse A Deng, Jersey et al.

Source: Brain: A Journal of Neurology; Jul2019, Vol. 142 Issue 7, p2068-2081, 14p

Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial.

Authors: Boxer, Adam L Qureshi, Irfan Ahlijanian, Michael et al.

Source: Lancet Neurology. Jun2019, Vol. 18 Issue 6, p549-558. 10p.

Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials.

Authors: Staffaroni, Adam M Ljubenkov, Peter A Kornak, John et al.

Source: Brain: A Journal of Neurology; Feb2019, Vol. 142 Issue 2, p443-459, 17p

What is the best way to motivate students in your subject?

Authors: BOXER, ADAM¹

Source: Impact (2514-6955). Spring2019, Issue 5, p10-11. 2p.

6 Remote Smartphone Cognitive and Motor Testing in Frontotemporal Dementia Research: Feasibility, Reliability, and Validity.

Authors: Staffaroni, Adam M Taylor, Jack Carson Clark, Annie L et al.

Source: Journal of the International Neuropsychological Society; 2023 Supplement, Vol. 29, p604-605, 2p